Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society

Immune checkpoint inhibitors (ICIs) including an anti-cytotoxic T-lymphocyte-associated antigen 4 inhibitor, anti-programmed cell death protein 1 (PD-1) inhibitors, and anti-PD-ligand 1 inhibitors are representative therapeutics for various malignancies. In oncology, the application of ICIs is curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Hyemi, Roh, Eun, Ahn, Chang Ho, Kim, Hee Kyung, Ku, Cheol Ryong, Jung, Kyong Yeun, Lee, Ju Hee, Kim, Eun Heui, Suh, Sunghwan, Hong, Sangmo, Ha, Jeonghoon, Moon, Jun Sung, Kim, Jin Hwa, Kim, Mi-kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2022
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816514/
https://www.ncbi.nlm.nih.gov/pubmed/36604955
http://dx.doi.org/10.3803/EnM.2022.1627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816514/
https://www.ncbi.nlm.nih.gov/pubmed/36604955
http://dx.doi.org/10.3803/EnM.2022.1627

Ejemplares similares